MedPath

ADVATE

ADVATE

Approved
DIN Number

02446413

Drug Class

Human

Market Date

N/A

Company
HC

takeda canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02446413
AIG Number0124180003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BD02 COAGULATION FACTOR VIII
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification20:28.16
Health Canada Classification

ACTIVE INGREDIENTS (1)

ANTIHEMOPHILIC FACTOR (RECOMBINANT)Active
Strength: 500 UNIT / VIAL
Monograph: ANTIHEMOPHILIC FACTOR (RECOMBINANT)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.